Regulation of Proinflammatory Cytokine Interleukin-6 (IL-6) Induction by NF-kappaB Signaling in Pandemic H1N1 Influenza A Virus-Infected Human Bronchial Epithelial Cells (45.29)

Zheng Xing,Wei Gao,Bingqian Qu,Xue Li,Yu Jin,Ku Yang,Carol Cardona
DOI: https://doi.org/10.4049/jimmunol.184.supp.45.29
2010-01-01
The Journal of Immunology
Abstract:Abstract The influenza A (H1N1) pandemic of 2009 is caused by a novel swine influenza virus, which has resulted in thousands of mortalities worldwide. Pulmonary failure due to over-induction of proinflammatory factors appeared to be the main cause in severe cases leading to death. To elucidate the pathogenesis of the novel H1N1 virus in humans, we infected human bronchial epithelial cells with A/Nanjing/NJU108/2009 (H1N1), isolated from a patient in Nanjing, China, and analyzed expression profiles of various cytokines and chemokines. We found that among proinflammatory cytokines, IL-6 was induced up to hundred and thousand fold after infection, while the levels of IL-1beta and IL-8 remained unchanged. This study aims to understand how NF-kappa B (NFκB) signaling pathway regulates the induction of IL-6 upon infection. Surprisingly, when a specific IKKalpha/beta inhibitor was used, IL-6 induction was not affected. IL-6 induction was, however, greatly suppressed by an NFκB1/p100 inhibitor, which indicates that the NFκB signaling was involved in the regulation of IL-6 but the classical NFkB pathway seems to be only partially implicated. We further examined the phosphorylation and activation of IKKs, NFκB1 and NFκB2, and other regulators in NFκB signaling. Our data demonstrated that a novel mechanism was employed in NFκB signaling pathway which regulates IL-6 induction and may play a critical role in pathogenesis in humans infected with the novel pandemic H1N1 influenza A virus.
What problem does this paper attempt to address?